Renal Disease Market Research Report - Forecast to 2023

Renal Disease Market Research Report - Forecast to 2023

ID: MRFR/HC/2289-HCRR | October, 2018 | Region: Global | 82 pages | Half-Cooked Research Reports

Global Renal disease Market information, by type (Acute kidney problems, Chronic kidney diseases, and others), by Diagnosis (Blood tests, Urine tests, Imaging tests, Removing a sample of kidney tissue for testing, and others), by Treatment (Medications, Dialysis, Kidney transplant, Surgery, Diet and others) - Forecast to 2023


Market Synopsis of Global Renal disease Market:


Market Scenario:


Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Global Renal disease Market is growing moderately. The growing prevalence of renal diseases is leading the market growth. Increasing R&D activities and clinical trials are major driving forces of the market. Increasing acquaintance and awareness among the patients, growing healthcare sector, government initiatives and new product launches are key factors for the global renal disease market.


The Global Renal disease market is growing at the CAGR of ~6.3% during the forecast period and expected to reach US$ 14291.2 million by 2023.



Study objectives of Global Renal disease Market:



  • To provide detailed analysis of the Global Renal disease market structure with historical and forecasted revenue for the next 7 years of the various segments and sub-segments of the Renal disease Market

  • To provide insights about the key drivers, restraints, opportunities and challenges that affecting the growth of the Renal disease market

  • To provide analysis of the market with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detail analysis of the market that segmented on the basis of type, by diagnosis, by treatment, and its sub-segments.

  • To provide detail analysis of global renal disease market mainly based on Value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.

  • To provide detail country level analysis of the market with respect to the current market size and future prospective

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Renal disease Market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the renal diseases market



FIGURE 1                   GLOBAL RENAL DISEASE MARKET, BY TYPE

 


Key Players for Global Renal disease Market:                                             


Some of the key players in this market are: Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), NephroGenex, Inc. (US), Novartis AG (Switzerland), Pfizer Inc.(US), Sanofi (France), Shire Pharmaceuticals Limited (Republic of Ireland), and others.




 
Research Methodology:





 Sources: WHO, National Foundation for Infectious Diseases, Directorate of Industries, Annual report, White paper, Company Presentation


 Segments:                                                                                                                                        


Global Renal disease Market has been segmented on the basis of type which comprise acute kidney problems (Prerenal, Postrenal, Renal), Chronic kidney diseases, and others. On the basis of diagnosis, it segmented into Blood Tests (Serum Creatinine, Glomerular Filtration Rate(GFR), Blood Urea Nitrogen (BUN), fasting blood glucose test), Urine test (Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test), Imaging test (Ultrasound, CT Scan ), Removing a sample of kidney tissue for testing. On the basis of treatment, it segmented into medication (High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, Medications to protect your bones), Dialysis (Hemodialysis, Peritoneal dialysis), kidney transplant (Deceased-donor kidney transplant, Living-donor kidney transplant, Pre-emptive kidney transplant ), surgery (Nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy , Extracorporeal shock wave lithotripsy (ESWL), and others), diet and others.



Regional Analysis of Global Renal disease Market:                   


Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment. 

Intended Audience



  • Renal disease medicines and device manufacturers

  • Renal disease medicine suppliers

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global Renal disease Market by Type

6.1 Acute kidney problems

6.1.1 Prerenal

6.1.2 Postrenal

6.1.3 Renal

6.2 Chronic kidney diseases

6.3 Others

7. Global Renal disease Market by Diagnosis

7.1 Blood Tests

7.1.1 Serum Creatinine

7.1.2 Glomerular Filtration Rate (GFR)

7.1.3 Blood Urea Nitrogen (BUN)

7.1.3 Fasting blood glucose test

7.2 Urine test

7.2.1 Urinalysis,

7.2.2 Protein urine test

7.2.3 Microalbuminuria test

7.2.4 Creatinine Clearance test

7.3 Imaging test

7.3.1 Ultrasound

7.3.2 CT Scan

7.4 Removing a sample of kidney tissue for testing

7.5 Others

8. Global Renal disease Market by Treatment

8.1 Medication

8.1.1 High blood pressure medications

8.1.2 Medications to lower cholesterol levels

8.1.3 Medications to treat anemia

8.1.4 Medications to relieve swelling

8.1.5 Medications to protect your bones

8.2 Dialysis

8.2.1 Hemodialysis

8.2.2 Peritoneal dialysis

8.3 kidney transplant

8.3.1 Deceased-donor kidney transplant

8.3.2 Deceased-donor kidney transplant

8.3.3 Pre-emptive kidney transplant

8.4 surgery

8.4.1 Nephrectomy and radical nephrectomy

8.4.2 Nephron-Sparing Surgery (NSS)

8.4.3 Nephrolithotripsy

8.4.4 Extracorporeal shock wave lithotripsy (ESWL)

8.5 Diet

8.6 Others

9. Global Renal disease Market by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 The US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.3 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10 Conclusion

10.1 Key findings

10.1.1 From CEO’s viewpoint

10.1.2 Unmet needs of the market

10.2 Key companies to watch

10.3 Prediction of Renal Disease Industry



1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global Renal disease Market by Type

6.1 Acute kidney problems

6.1.1 Prerenal

6.1.2 Postrenal

6.1.3 Renal

6.2 Chronic kidney diseases

6.3 Others

7. Global Renal disease Market by Diagnosis

7.1 Blood Tests

7.1.1 Serum Creatinine

7.1.2 Glomerular Filtration Rate (GFR)

7.1.3 Blood Urea Nitrogen (BUN)

7.1.3 Fasting blood glucose test

7.2 Urine test

7.2.1 Urinalysis,

7.2.2 Protein urine test

7.2.3 Microalbuminuria test

7.2.4 Creatinine Clearance test

7.3 Imaging test

7.3.1 Ultrasound

7.3.2 CT Scan

7.4 Removing a sample of kidney tissue for testing

7.5 Others

8. Global Renal disease Market by Treatment

8.1 Medication

8.1.1 High blood pressure medications

8.1.2 Medications to lower cholesterol levels

8.1.3 Medications to treat anemia

8.1.4 Medications to relieve swelling

8.1.5 Medications to protect your bones

8.2 Dialysis

8.2.1 Hemodialysis

8.2.2 Peritoneal dialysis

8.3 kidney transplant

8.3.1 Deceased-donor kidney transplant

8.3.2 Deceased-donor kidney transplant

8.3.3 Pre-emptive kidney transplant

8.4 surgery

8.4.1 Nephrectomy and radical nephrectomy

8.4.2 Nephron-Sparing Surgery (NSS)

8.4.3 Nephrolithotripsy

8.4.4 Extracorporeal shock wave lithotripsy (ESWL)

8.5 Diet

8.6 Others

9. Global Renal disease Market by Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 The US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.3 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10 Conclusion

10.1 Key findings

10.1.1 From CEO’s viewpoint

10.1.2 Unmet needs of the market

10.2 Key companies to watch

10.3 Prediction of Renal Disease Industry

11 Appendix